Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1966 1
1967 1
1968 1
1969 1
1984 1
2005 3
2006 1
2007 4
2008 4
2009 2
2010 3
2011 1
2012 1
2013 1
2014 1
2015 1
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

27 results

Results by year

Filters applied: . Clear all
Page 1
Intrathecal trastuzumab: dose matters.
Hofer S, Mengele K, Stemmler HJ, Schmitt M, Pestalozzi B. Hofer S, et al. Among authors: mengele k. Acta Oncol. 2012 Sep;51(7):955-6. doi: 10.3109/0284186X.2012.673736. Epub 2012 Apr 23. Acta Oncol. 2012. PMID: 22524214 No abstract available.
Emerging biomarkers in breast cancer care.
Napieralski R, Brünner N, Mengele K, Schmitt M. Napieralski R, et al. Among authors: mengele k. Biomark Med. 2010 Aug;4(4):505-22. doi: 10.2217/bmm.10.73. Biomark Med. 2010. PMID: 20701440 Review.
European Organisation for Research and Treatment of Cancer (EORTC) Pathobiology Group standard operating procedure for the preparation of human tumour tissue extracts suited for the quantitative analysis of tissue-associated biomarkers.
Schmitt M, Mengele K, Schueren E, Sweep FC, Foekens JA, Brünner N, Laabs J, Malik A, Harbeck N; European Organisation for Research and Treatment of Cancer Pathobiology Group. Schmitt M, et al. Among authors: mengele k. Eur J Cancer. 2007 Mar;43(5):835-44. doi: 10.1016/j.ejca.2007.01.008. Epub 2007 Feb 23. Eur J Cancer. 2007. PMID: 17321128
Y-box-binding protein YB-1 identifies high-risk patients with primary breast cancer benefiting from rapidly cycled tandem high-dose adjuvant chemotherapy.
Gluz O, Mengele K, Schmitt M, Kates R, Diallo-Danebrock R, Neff F, Royer HD, Eckstein N, Mohrmann S, Ting E, Kiechle M, Poremba C, Nitz U, Harbeck N. Gluz O, et al. Among authors: mengele k. J Clin Oncol. 2009 Dec 20;27(36):6144-51. doi: 10.1200/JCO.2008.19.6261. Epub 2009 Nov 9. J Clin Oncol. 2009. PMID: 19901122 Clinical Trial.
27 results